Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery

Parse Biosciences, a leading provider of accessible and scalable single-cell sequencing solutions, today announced the generation of the world’s largest single-cell dataset to date, totaling 100 million cells. This impressive milestone was achieved in just one month using Parse Biosciences’ GigaLab and done in partnership with Vevo Therapeutics to advance their AI-based drug discovery efforts.

Hani Goodarzi, Kevan Shokat, and Johnny Yu are the UCSF co-founders, and we congratulate them all!

MORE